Add like
Add dislike
Add to saved papers

Comparison of conventional DWI and intravoxel incoherent motion in differentiating between chromophobe renal cell carcinoma and renal oncocytoma: a preliminary study.

OBJECTIVE: Quantitative comparison of the diagnostic efficacy of conventional diffusion-weighted imaging (DWI) and intravoxel incoherent motion (IVIM) in differentiating between chromophobe renal cell carcinoma(ChRCC) from renal oncocytoma(RO).

METHODS: A total of 48 patients with renal tumors who had undergone DWI and IVIM were divided into two groups-ChRCC (n = 28) and RO (n = 20) groups, and the apparent diffusion coefficient (ADC), true diffusivity (D), pseudo-diffusion coefficient (D*), perfusion fraction (f) and their diagnostic efficacy were compared between the two groups.

RESULTS: The D* values were higher in the ChRCCs group compared to the RO groups (0.019 ± 0.003mm2/s vs.0.008 ± 0.002 mm2/s, p < 0.05). Moreover, the ADC, D and f values were higher in ROs compared to ChRCCs (0.61 ± 0.08 × 10-3mm2/s vs. 0.51 ± 0.06 × 10-3mm2/s, 1.02 ± 0.15 × 10-3mm2/s vs. 0.86 ± 0.07 × 10-3mm2/s, 0.41 ± 0.05 vs. 0.28 ± 0.02, p < 0.05). The areas of the ADC, D, D* and f values under the ROC curves in differentiating ChRCCs from ROs were 0.713, 0.839, 0.856 and 0.906, respectively. The cut-off values of ADC, D, D* and f were 0.54, 0.91, 0.013 and 0.31, respectively. The AUC, sensitivity, specificity and accuracy of the f values were 0.906, 89.3%, 80.0% and 89.6%, respectively. For pairwise comparisons of ROC curves and diagnostic efficacy, IVIM parameters, ie, D, D*and f offered better diagnostic accuracy than ADC in differentiating ChRCCs from ROs(p = 0.013, 0.016 and 0.008) with f having the highest diagnostic accuracy.

CONCLUSION: IVIM parameters presented better performance than ADC in differentiating ChRCCs from ROs.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app